Author:
Buch Maya H.,Pavitt Sue,Parmar Mahesh,Emery Paul
Publisher
Springer Science and Business Media LLC
Reference90 articles.
1. Lee, D. M. & Weinblatt, M. E. Rheumatoid arthritis. Lancet 358, 903–911 (2001).
2. Hench, P. S. et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc. Staff Meet. Mayo Clin. 24, 181–197 (1949).
3. Schwieterman, W. D. Issues in the design of new clinical trials for rheumatoid arthritis therapeutics. Nat. Clin. Pract. Rheumatol. 4, 641–648 (2008).
4. O'Dell, J. R. et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N. Engl. J. Med. 334, 1287–1291 (1996).
5. Haagsma, C. J. et al. Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy. Br. J. Rheumatol. 33, 1049–1055 (1994).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献